Concentrations of gentamicin in serum and bronchial lavage fluid after intravenous and aerosol administration of gentamicin to horses

American Journal of Veterinary Research

Volumn 61, Issue 10, 2000, Pages 1185-1190

  McKenzie III, Harold C ^a   Murray, Michael J ^a  

^a MARION DUPONT SCOTT EQUINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN;

AEROSOL; ARTICLE; BRONCHOPNEUMONIA; DRUG BLOOD LEVEL; DRUG DETERMINATION; FEMALE; HORSE; HUMAN; LEUKOCYTE COUNT; LUNG FLUID; MALE; TRACHEOBRONCHIAL TOILET;

ANIMALIA; BACTERIA (MICROORGANISMS); EQUIDAE; EQUUS CABALLUS;

EID: 0033809088     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2000.61.1185     Document Type: Article

References (63)

1. Geor RJ. Performance-limiting conditions of the lungs. In: Kobluk CN, Ames TR, Geor RJ, eds. The horse: diseases and clinical management. 1st ed. Philadelphia: WB Saunders Co, 1995;263-273.
2. Burrell MH, Wood JL, Whitwell KE, et al. Respiratory disease in thoroughbred horses in training: the relationships between disease and viruses, bacteria and environment. Vet Rec 1996;139:308-313.
3. Reed SR. Pneumonia in horses, in Proceedings. Dubai Int Equine Symp 1997;265-274.
4. Bergogne-Berezin E, Vallee E. Pharmacokinetics of antibiotics in respiratory tissues and fluids. In: Pennington JE, ed. Respiratory infections: diagnosis and management. 3rd ed. New York: Raven Press, Ltd, 1994;715-740.
5. Wung GA, Pierce TH, Goldstein E, et al. Penetration of antimicrobial agents into bronchial secretions. Am J Med 1975; 59:219-223.
6. Valcke Y, Pauwels R, Van der Straeten M. Pharmacokinetics of antibiotics in the lungs. Eur Respir J 1990;715-722.
7. Baldwin DR, Honeybourne D, Wise R. Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrob Agents Chemother 1992;36:1171-1175.
8. Thys J-P, Aoun M, Klastersky J. Local antibiotic therapy for bronchopulmonary infections In: Pennington JE, ed. Respiratory injections: diagnosis and management. 3rd ed. New York: Raven Press, Ltd, 1994;741-766.
9. Godber LM, Walker RD, Stein GE, et al. Pharmacokinetics, nephroloxicosis, and in vitro antibacterial activity associated with single versus multiple (three times) daily gentamicin treatments in horses. Am J Vet Res 1995;56:613-618.
10. Bayly W, Liggitt H, Huston L, et al. Stress and its effect on equine pulmonary mucosal defenses, in Proceedings. Am Assoc Equine Pract 1986;253-262.
11. Rose RJ, Hodgson DR. Lower respiratory tract diseases. In: Rose RJ, Hodgson DR, eds. Manual of equine practice. Philadelphia: WB Saunders Co, 1993;160-169.
12. Folz SD, Hanson BJ, Griffin AK, et al. Treatment of respiratory infections in horses with ceftiofur sodium. Equine Vet J 1992;24:300-304.
13. Montgomery AB, Debs RJ, Luce JM, et al. Selective delivery of pentamidine to the lung by aerosol. Am Rev Respir Dis 1988;137:477-478.
14. Vermeersch H, Vandenbossche G, Remon JP, et al. Pharmacokinetics of nebulized sodium ceftiofur in calves. J Vet Pharmacol Ther 1996;19:152-154.
15. Whelan AM, Hahn NW. Oplimizing drug delivery from metered-dose inhalers. Dicp 1991;25:638-645.
16. Lipworth BJ. Pharmacokinetics of inhaled drugs. Br J Clin Pharmacol 1996;42:697-705.
17. Duvivier DH, Votion D, Vandenput S, et al. Aerosol therapy in the equine species. Vet J 1997;154:189-202.
18. Le Conte PGP, Peltier P, et al. Lung distribution and pharmacokinetics of aerosolized tobramycin. Am Rev Respir Dis 1993;147:1279-1282.
19. Chaleva El, Vasileva IV, Savova MD. Absorption of lincomycin through the respiratory pathways and its influence on alveolar macrophages after aerosol administration to chickens. Res Vet Sci 1994;57:245-247
20. Baran D, de Vuyst P, Ooms HA. Concentration of tobramycin given by aerosol in the fluid obtained by bronchoalveolar lavage. Respir Med 1990;84:203-204.
21. Palmer LB, Smaldone GC, Simon SR, et al. Aerosolized antibiotics in mechanically ventilated patients: delivery and response. Crit Care Med 1998;26:31-39.
22. Berendt RF, Long GG, Walker JS. Treatment of respiratory Klebsiella pneumoniae infection in mice with aerosols of kanatnycin. Antimicrob Agents Chemother 1975;8:583-590.
23. Jensen T, Pedersen SS, Garne S, et al. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimicrob Chemothecr 1987;19: 831-838.
24. Orcutt TA, Godwin CR, Pizzo PA, et al. Aerosolized pentamidine: a well-tolerated mode of prophylaxis against Pneumocystis carinii pneumonia in older children with human immunodeficiency virus infection. Pediatr Infect Dis J 1992;11:290-294.
25. Ramsey BW, Dorkin HL, Eisenberg JD, et al. Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med 1993;328:1740-1740.
26. Sustronck B, Deprez P, Muylle E, et al. Evaluation of the nebulisation of sodium ceftiofur in the treatment of experimental Pastcurella haemolytica bronchopneumonia in calves. Res Vet Sci 1995;59:267-271.
27. Rhodes CH, Genetzky RM. Nebulization therapy in the foal. Iowa State Univ Vet 1982;44:104-108.
28. Clarke AE Practicalities of nebulisation. Equine Vet Educ 1991;3:45-49.
29. Wilson WD. Foal pneumonia. In: Robinson NE, ed. Current therapy in equine medicine. 3rd ed. Philadelphia: WB Saunders Co. 1992;406-473.
30. Easter JL, Hague BA, Brumbaugh GW et al. Effects of post-operative peritoneal lavage on pharmacokinetics of gentamicin in horses after celiotomy. Am J Vet Res 1997;58:1166-1170.
31. Schumacher J, Wilson RC, Spano JS, et al. Effect of diet on gentamicin-induced nephrotoxicosis in horses. Am J Vet Res 1991;52:1274-1278.
32. Pennington JE. Penetration of antibiotics into respiratory secretions. Rev Infect Dis 1981;3:67-73.
33. Braude AC, Hornstein A, Klein M. et al. Pulmonary disposition of tobramycin. Am Rev Respir Dis 1983;127:563-565.
34. Smith BR, LeFrock JL. Bronchial tree penetration of antibiotics. Chest 1983;83:904-908.
35. Valeke Y, Pauwels R, Van der Straeten M. The penetration of aminoglycosides into the alveolar lining fluid of rats. The effect of airway inflammation. Am Rev Respir Dis 1990;142: 1099-1103.
36. Sweeney C, Rossier Y, Ziemer EL, et al. Effects of lung site and fluid volume on results of bronchoalveolar lavage fluid analysis in horses Am J Vet Res 1992;53:1376-1379.
37. Schmekel B. A critical view on lavage sampling techniques. Agents Actions Suppl 1990;30:133-143.
38. Chinard FP Quantitative assessment of epithelial lining fluid in the lung. Am J Physiol 1992;263:617-618.
39. Baldwin DR, Wise R, Andrews JM, et al. Microlavage: a technique for determining the volume of epithelial lining fluid. Thorax 1991;46:658-662.
40. McGorum BC, Dixon PM, Halliwell REW, et al. Evaluation of urea and albumen as endogenous markers of dilution of equine bronchoalveolar lavage fluid. Res Vet Sci 1993;55:52-56.
41. Valeke YJ, Vogelaers DP, Colardyn FA, et al. Penetration of netilmicin in the lower respiratory tract after once-daily dosing. Chest 1992;101:1028-1032.
42. Von Wiehert P, Joseph K, Muller B, et al. Bronchoalveolar lavage. Quantitation of intraalveolar fluid? Am Rev Respir Dis 1993;147:148-152.
43. Marcy TW, Merrill WW, Rankin JA, et al. Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage. Am Rev Respir Dis 1987;135:1276-1280.
44. Craig WA. Once-daily versus multiple-daily dosing of aminoglycosides. J Chemother 1995;7 (suppl 2):47-52.
45. Smith AL, Ramsey B. Aerosol administration of antibiotics. Pediatr Pulmonol Suppl 1995;11:68-69.
46. Votion D, Ghafir Y, Munsters K, et al. Aerosol deposition in equine lungs following ultrasonic nebulisation versus jet aerosol delivery system. Equine Vet J 1997;29:388-393.
47. Gough PA, Jordan NS. A review of the therapeutic efficacy of aerosolized and endotracheally instilled antibiotics. Pharmacotherapy 1982;2:367-377.
48. Hall CB, McBride JT. Pulmonary infections. In: Moren F, Dolovich MB, Newhouse MT, et al, eds. Aerosols in medicine. Principles, diagnosis and therapy, Elsevier Science Publishers BV, 1993;291-301.
49. Hiller FC. Therapeutic aerosols: an overview from a clinical perspective. In: Mickey AJ, ed. Pharmaceutical inhalation aerosol technology. New York: Marcel Dekker Inc, 1992;289-306.
50. Chua HL, Collis GG, Le Souef PN. Bronchial response to nebulized antibiotics in children with cystic fibrosis. Eur Respir J 1990;3:1114-1116.
51. Dally MB, Kurrle S, Breslin ABX. Ventilatory effects of aerosol gentamicin. Thorax 1978;33:54-56.
52. Dickie KJ, de Groot WJ. Ventilatory effects of aerosolized kanamycin and polymyxin. Chest 1973;63:694-697.
53. Chua HL, Walker SL, LeSouef PN, et al. Comparison of efficacy of salbutamol and sodium cromoglycate in the prevention of ticarcillin-induced bronchoconstriction. Pediatr Pulmonol 1993;16: 311-315.
54. Ilowite JS, Gorvoy JD, Smaldone GC. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am Rev Respir Dis 1987;136:1445-1449.
55. MacLusky IB, Gold R, Corey M, et al. Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatr Pulmonol 1989;7:42-48.
56. Stephens D, Garey N, Isles A, et al. Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis. Pediatr Inject Dis 1983;2:209-211.
57. Steinkamp G, Tummler B, Gappa M, et al. Long-term tobramycin aerosol therapy in cystic fibrosis. Pediatr Pulmonol 1989; 6:91-98.
58. Smith AL, Ramsey BW, Hedges DL, et al. Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis. Pediatr Pulmonol 1989;7:265-271.
59. Schaad UB, Wedgwood-Krucko J, Suter S, et al. Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis. J Pediatr 1987; 111:599-605.
60. Sweeney CR, Rossier Y, Ziemer EL, et al. Effect of prior lavage on bronchoalveolar lavage fluid cell population of lavaged and unlavaged lung segments in horses. Am J Vet Res 1994;55:1501-1504.
61. Saiman L. Selected topics in novel methods of antibiotic delivery: aerosolized antibiotics and lipid preparations. Adv Pediatr Infect Dis 1998; 13:349-376.
62. Weber A, Morlin G, Cohen M, et al. Effect of nebulizer type and antibiotic concentration on device performance. Pediatr Pulmonol 1997;23:249-260.
63. O'Callaghan C, Barry PW. The science of nebulized drug delivery. Thorax 1997;52:31-44.